États-Unis · Plateformes & données · MarketBeat

Lyell Immunopharma (NASDAQ:LYEL) Stock Bumped Up to "Hold" by Wall Street Zen

Publié par MarketBeat · États-Unis il y a 3 h

Wall Street Zen upgraded shares of Lyell Immunopharma from a "sell" rating to a "hold" rating in a research report on Sunday.

Lire l'article complet sur MarketBeat Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.marketbeat.com)

À lire aussi

The Motley Fool

Alphabet's 2 Classes of Common Stock Trade About 1% Apart. Here's the One I'd Buy.

5 big analyst AI moves: ’Uniquely catalyst-rich’ months ahead for SpaceX

Adobe Stock Looks Different After Record Quarter And Raised Guidance

Musk says Ukraine violated Starlink terms with offensive drone strikes

My father-in-law, 81, sold his $75,000 home to pay his daughter’s $50,000 debt. How can I keep him from becoming destitute?

Gold prices break $4,000 as investors brace for crucial test